[The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].
The nootropic agent pyracetam was used in patients suffering of chronic bronchitis associated with concomitant atherosclerosis. Pyracetam was administered intravenously in saline solutions. It was found that the group of patients receiving pyracetam revealed earlier normalization of clinico-laboratory indices. Pyracetam also produced immunocorrective and antioxidant effect resulting in normalization immunity values and activity of lipid peroxidation.
Nikitin
A V
AV
Chesnokova
I V
IV
Sysoeva
L I
LI
D000368:Aged; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D001991:Bronchitis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D002908:Chronic Disease; D004341:Drug Evaluation; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008875:Middle Aged; D010889:Piracetam / Q000627:therapeutic use*
D010889:Piracetam
Effektivnost' piratsetama pri lechenii bol'nykh khronicheskim bronkhitom i soputstvuiushchim aterosklerozom.